Energy-Coupling Factor Transporters as Novel Antimicrobial TargetsBousis, S., Setyawati, I., Diamanti, E., Slotboom, D. J. & Hirsch, A. K. H., Feb-2019, In : Advanced Therapeutics. 2, 2, 17 p., 1800066.
Research output: Contribution to journal › Article › Academic › peer-review
In an attempt to find new antibiotics, novel ways of interfering with important biological functions should be explored, especially with those which are necessary or even irreplaceable for bacterial survival, growth, and virulence. The purpose of this review is to highlight B-type vitamin transporters from the energy-coupling factor (ECF) family, which are not present in humans, as potential antimicrobial targets. In addition, a druggability analysis of an ECF transporter for folic acid and sequence-conservation studies in seven prominent pathogens revealed new druggable pockets. Evaluation of the presence of de novo biosynthetic routes for the vitamins in question in the seven pathogens confirmed that this target class holds promise for the discovery of antimicrobial drugs with a new mechanism of action, possibly on a broad-spectrum level.
|Number of pages||17|
|Publication status||Published - Feb-2019|
- antimicrobials, B-type vitamins, energy-coupling factor transporters, S-components, uptake, STAPHYLOCOCCUS-AUREUS INFECTIONS, ATP-BINDING, FOLIC-ACID, ECF TRANSPORTER, S-COMPONENT, COENZYME-A, CONFORMATIONAL-CHANGES, THIAMIN BIOSYNTHESIS, VANCOMYCIN-RESISTANT, COMPARATIVE GENOMICS